Skip to main content
Experimental Biology and Medicine logoLink to Experimental Biology and Medicine
. 2015 Mar;240(3):403–408. doi: 10.1177/1535370215570829

Landscape of Pin1 in the cell cycle

Cheng-Han Lin 1, Hao-Yi Li 1, Yu-Cheng Lee 1, Marcus J Calkins 1, Kuen-Haur Lee 2, Chia-Ning Yang 3,, Pei-Jung Lu 1,
PMCID: PMC4935233  PMID: 25662955

Abstract

Pin1 is a peptidyl-prolyl isomerase which plays a critical role in many diseases including cancer and Alzheimer's disease. The essential role of Pin1 is to affect stability, localization or function of phosphoproteins by catalyzing structural changes. Among the collection of Pin1 substrates, many have been shown to be involved in regulating cell cycle progression. The cell cycle disorder caused by dysregulation of these substrates is believed to be a common phenomenon in cancer. A number of recent studies have revealed possible functions of several important Pin1-binding cell cycle regulators. Investigating the involvement of Pin1 in the cell cycle may assist in the development of future cancer therapeutics. In this review, we summarize current knowledge regarding the network of Pin1 substrates and Pin1 regulators in cell cycle progression. In G1/S progression, cyclin D1, RB, p53, p27, and cyclin E are all well-known cell cycle regulators that are modulated by Pin1. During G2/M transition, our lab has shown that Aurora A suppresses Pin1 activity through phosphorylation at Ser16 and cooperates with hBora to modulate G2/M transition. We conclude that Pin1 may be thought of as a molecular timer which modulates cell cycle progression networks.

Keywords: Pin1, cell cycle, Aurora A, hBora

Introduction

Pin1 (peptidyl-prolyl cis-trans isomerase) is a unique enzyme that specifically isomerizes phosphor-Ser-Pro or phosphor-Thr-Pro (pSer/Thr-Pro) peptide bonds, and its dysregulation has been implicated in a number of pathological conditions, including aging, immune response, apoptosis, Alzheimer's disease and multiple cancers.15 Up-regulation of Pin1 has been observed in many types of cancers including lung, breast, esophageal squamous cell carcinoma (ESCC) and prostate cancers, and is generally regarded as a biomarker for poor prognosis.6,7 Several studies have reported possible mechanisms of Pin1 up-regulation. For example, increased Pin1 level was found to be increased through the oncogenic Neu/Ras pathway via E2F to promote tumorigenesity in mammary epithelial cells.8 In addition, Pin1 interacts with Notch1 and Notch4 to activate their transcriptional activity. The activated Notch1 and Notch4 directly induce transcription of Pin1 to form positive feedback loop.9,10 In prostate cancer, dramatic decreases in miR-296-5p resulted in increased levels of Pin1;11 miR200c down-regulate Pin1 expression both in mRNA and protein to decrease the abundance and self-renewal activity of breast cancer stem cells.12 These results demonstrate an alternative regulatory mechanism of Pin1 and emphasize the importance of Pin1. Because many Pin1 substrates are critical cell cycle regulators (such as cyclin D1 and RB), up-regulation of Pin1 is thought to promote tumor progression.

Pin1 contains an N-terminal WW domain and a C-terminal PPIase domain. Client proteins containing the pSer/Thr-Pro motif are recognized by the WW domain and isomerization of the peptide bond is catalyzed by the PPIase domain. Pin1-mediated protein isomerization is correlated to several functional outcomes for client proteins, including alterations in catalytic activity, protein stability, interactions with other proteins, and subcellular localization.5,13 Phosphorylation is the most common post-translational modification in cells, and global mass spectrometry analysis has revealed that over 96% of all phospho-proteins in the cell are phosphorylated at serine and threonine residues.14 Because Ser/Thr phosphorylation is a widespread and crucial mechanism of signal transduction, tight regulation of phospho-protein function becomes an important issue. Thus, Pin-mediated isomerization of pSer/Thr-Pro motif containing proteins represents a critical mechanism in signal transduction.

Pin1 regulation of the cell cycle

In normal cell physiology, Cyclin/Cdk complexes regulate progression through the cell cycle, and their directed degradation is often responsible for triggering advancement through the phases. The cell cycle is a phosphorylation dependent progression and many of the phosphorylated proteins are regulated by Pin1 (Table 1). In addition, many kinases that act on Ser/Thr-Pro motifs, such as cyclin-dependent kinases (CDKs), Jun-N-terminal protein kinases (JNKs), polo-like kinases (PLKs) and glycogen synthase kinases 3 (GSK3) play major roles in cell cycle regulation. Accordingly, Pin1 may contribute to cell cycle regulation through isomerization of client proteins which are phosphorylated by CDKs, JNKs, PLKs and GSK3. Furthermore, Pin1 was first identified as a mitosis regulator and subsequent studies have solidified and further elucidated the importance of Pin1 in G2-M phase.15,16 Moreover, recent studies have revealed an additional role for Pin1 in controlling G1/S phase.8,17,18 Several studies have also shown that decreased Pin1 expression leads to cell cycle attenuation.15,1921 Overall, Pin1 plays a critical role as a cell cycle modulator to promote cell cycle progression. However, the mechanisms by which Pin1 is regulated remain unclear. Pin1 protein level does not significantly fluctuate during cell cycle progression,1921 but the binding partners of Pin1 are dynamically regulated by transcriptional and post-transcriptional mechanisms. Many Pin1 partners are critical cell cycle regulators that are expressed or activated in a specific cell cycle phase to tightly regulate cell cycle progression (ex. Cyclin D1 only exists in G1 phase and hBora accumulates in G2 phase). Therefore, Pin1 may regulate specific substrates as they appear in different phases of cell cycle. Discovering mechanisms to regulate the activity of Pin1 has become an important pursuit in understanding control of cell cycle progression. Recently, we found that Pin1 may be regulated either by miRNA or post-translational modification by Aurora A (Table 1).11,21 In the following sections, we will describe specific molecular interactions that taken together comprise the landscape of Pin1 activity in cell cycle progression (Figure 1).

Table 1.

Pin1 substrates and regulators in cell cycle

Pin1 substrates
Protein Pin1 function Pin1 binding motif References
G1/S phase
 cyclin D1 Stabilization, localization, transcription Thr286 22,26,27
 RB Inactivation Ser608 and Ser612 28
 p53 Stabilization and activation Ser33, Ser46, Thr81 and Ser315 23,2936
 p27 Stabilization Thr187 24
 cyclin E Degradation Thr380 39
G2/M phase
 hBora Degradation Ser274 and Ser278 21
 CDC25 Inhibit phosphatase activity Thr48 and Thr67 16
 Wee1 Inactivation Thr186 47
Pin1 regulators
Protein
Function Pin1 outcome References
 E2F Transcriptional activation Increase protein level 8
 Notch1 Transcriptional activation Increase protein level 9,10
 Notch4 Transcriptional activation Increase protein level 9,10
 DAPK1 phosphorylation at Ser71 Inhibit catalytic activity 41
 PLK1 phosphorylation at Ser56 Stabilization 16,46
 Arora A phosphorylation at Ser16 Inhibit binding ability 21
 PKA phosphorylation at Ser16 Inhibit binding ability 18
 PP2A Dephosphorylation at Ser16 Recover binding ability 44
 miR-296-5p Translational repression Decrease protein level 11
 miR-200c mRNA degradation Decrease protein level 12

Figure 1.

Figure 1

Pin1 regulating network in cell cycle. During G1/S phase, Pin1 promotes cyclin D1 overexpression and RB phosphorylation. The phosphorylated RB releases E2F, which is a transcriptional factor to enhance Pin1 expression. Pin1 stimulates cyclin E degradation in S phase. During G2 phase, Aurora A inactive Pin1 and active PLK result in CDC25 activation triggers G2/M transition. During the G2/M transition, GSK-3β interacts with and phosphorylates hBora at S274/S278, and in the meantime, Aurora A interacts with and phosphorylates Pin1 at Ser16 to disrupt Pin1 function by suppressing Pin1 binding to phospho-hBora and thus preventing β-TrCP-mediated premature hBora degradation. Therefore, Aurora A forms a complex with phospho-hBora to phosphorylate Plk1 at Thr210 and activates Plk1. Plk1 activates CDC25 result in the activation of the Cyclin-B1/CDK1 complex and promotes mitotic entry. After mitotic entry, Pin1 could recover the binding activity and enhance protein stability through PP2A and PLK1. The active Pin1 promotes the degradation of hBora. Aurora A is then available to bind with TPX2 result in mitotic spindle assembly. Wee1 is phosphorylated at Tyr168 by CDK1 and Pin1 isomerize phosphorylated Wee1 inactivation.

Pin1 in G1/S phase

The role of Pin1 in G1/S phase is relatively unknown compared to G2/M phase. However, several known Pin1 substrates, such as cyclin D1, RB, p53 and p27, are centrally involved in G1/S phase.17,2224 In addition, E2F, which is a G1-S transition initiator, is known to enhance Pin1 expression in G1/S phase.8 All the partners of Pin1 described in this review are critical regulators of the cell cycle and have tight connectivity in cell cycle progression. This is clearly true for the Pin1 interacting proteins that are involved in G1-S phase. During early G1 phase, E2F is bound and inhibited by RB, whereas the interaction is disrupted by RB phosphorylation in mid-G1 phase. Once E2F is released from RB, it will turn on cyclin D1 transcription to trigger cell cycle progression in G1 phase.25 In this section, we will provide an overview of the role of Pin1 in G1/S phase.

Pin1 and cyclin D1

Cyclin D1 is an essential factor for cell cycle progression, especially in G0, G1 and S phase. Pin1 increases cyclin D1 expression through transcriptional and post-translational regulation. Up-regulation of Pin1 has been demonstrated to increase cyclin D1 mRNA expression through c-Jun/AP-1 and β-catenin/TCF mediated transactivation.26,27 In addition, Pin1 directly interacts with cyclin D1 at the phosphorylated Thr286-Pro motif and catalyzes isomerization of cyclin D1. This interaction between Pin1 and cyclin D1 inhibits nuclear export of cyclin D1, resulting in stabilization and accumulation of cyclin D1 in the nucleus.22

Pin1 and RB

RB, which is a key regulator of G1-S transition, interacts with E2F and inhibits E2F activity in early G1 phase, until RB is phosphorylated by CDKs.25 Pin1 directly binds to pRB and triggers RB hyperphosphorylation, resulting in E2F release and activation.28 Subsequently, activation of E2F initiates G1-S phase transition. Moreover, activated E2F can bind to the Pin1 promoter and enhance Pin1 expression to form a positive feedback loop.

Pin1 and p53

The activation of p53 is a well-known response to DNA damage, which causes cell cycle arrest or apoptosis. Under normal conditions, MDM2 binds to p53 and promotes ubiquitin-mediated proteasome degradation. DNA damage specifically induces p53 phosphorylation on Ser/Thr-Pro motifs.23 There are four Ser-Pro motifs (Ser33, Ser46, Ser127, and Ser315) and two Thr-Pro motifs (Thr81 and Thr150) in p53. DNA damage induces Pin1 phosphorylation on Ser46 by HIPK2, PKCδ and P38, while phosphorylation of Thr81 is induced by JNK.2932 Pin1 binds to Thr81 phosphorylated p53 and prevents the interaction between p53 and MDM2, thereby promoting p53 stabilization.33,34 In addition, Pin1 is required for p53 transcriptional activity. Pin1 is recruited to p53-responsive promoters to promote binding and acetylation by p300 after DNA damage. Furthermore, when p53 is phosphorylated at Ser46, Pin1 promotes dissociation of p53 from the apoptosis inhibitor iASPP.35 Interestingly, Pin1 also binds and stabilizes HIPK2, which is known to phosphorylate p53 on Ser46. Therefore, this interaction forms a feedback loop by enhancing phosphorylation of p53 at Ser46 to block interaction of iASPP and promote apoptosis.35,36

Pin1 and p27

p27/Kip inhibits checkpoint kinase CDK2/cyclinE and functions as a negative regulator of G1-S transition. The activity of p27 is regulated by phosphorylation, synthesis and degradation. CDK2 phosphorylates p27 at Thr187, and this phosphorylation allows association between p27 and the SCF complex, triggering the proteolytic degradation of p27. The degradation of p27 prevents cell cycle arrest at G1 phase.37 It has been shown that the phosphorylated Thr-187-Pro motif in p27 is a functional Pin1 binding site. Therefore, Pin1 catalyzes a conformational change in p27, and thus mediates p27 stability and G1-S transition.24

Pin1 and cyclin E

Cyclin E is synthesized and interacts with CDK2 during G1-S transition. This complex phosphorylates RB1 and then in turn releases and activates E2F downstream genes required to execute the G1-S transition. Therefore, cyclin E degradation is required for proper cell cycle progression. GSk3β phosphorylates cyclin E at the Thr380-Pro motif.38 Phosphorylated cyclin E interacts with Pin1,39 and the Pin1-cyclin E complex then interacts with E3 ligase (FBXW7α). This interaction triggers Pin1 to catalyze a conformational change in cyclin E, leading to further interaction with another E3 ligase (FBXW7γ), which results in the degradation of cyclin E.2 Accordingly, Pin1 mediates cyclin E degradation in G1-S transition.

Pin1 in centrosome amplification

Pin1 is involved in the regulation of centrosome duplication, and overexpression of Pin1 interferes with proper centrosome amplification, resulting in multipolar spindles in mitosis, chromosome missegregation and aneuploidy.40 This effect can be modulated by Death-associated protein kinase 1 (DAPK1). DAPK1 is a positive mediator of gamma-interferon induced programmed cell death, and inactivates Pin1 PPIase domain by phosphorylation on Ser71. It was previously shown that DAPK1 can suppress Pin1-mediated centrosome amplification and cell transformation.41

Pin1 in G2/M phase

Pin1 and the hBora/Aurora A network

The function of Pin1 was first revealed as a negative regulator in mitosis. Evidence for this came from modulating Pin1 protein levels in HeLa cells. Pin1 depletion was found to cause premature entry into mitosis and mitotic arrest, whereas the overexpression of Pin1 inhibited the G2/M transition.15,16,19 These results suggested that Pin1 is essential for mitotic regulation and acts as a negative regulator of the G2/M transition by attenuating mitosis-promoting factor activity. However, the mechanism of this negative regulation is still unclear. Recently, our lab has described a cooperation between the regulatory network of Pin1 and Aurora A/hBora to modulate G2/M transition.21,42 Since Pin1 levels do not significantly fluctuate during cell-cycle progression,19 post-translational modification is likely a critical regulatory mechanism to alter Pin1 function. Several kinases and phosphatases have been shown to activate or stabilize Pin1 (Table 1). These include Aurora A and PKA, both of which phosphorylate Pin1 at Ser16 and inhibit Pin1 activity.

hBora, which is an activator of Aurora A, is phosphorylated by glycogen synthase kinase 3β (GSK3β) at Ser274 and Ser278, resulting in hBora accumulation in G2 phase. Phosphorylated-hBora cooperates with Aurora A to phosphorylate and activate PLK1 at Thr210 and promote mitotic entry.43 Activated PLK1, in turn, activates CDC25, which leads to the dephosphorylation of Thr14 and Tyr15 in CDK1, and triggers activation of the Cyclin-B/CDK1 complex. This activation initiates mitotic entry. Thus, the GSK3β-mediated phosphorylation of hBora in G2 phase is an essential event for mitotic entry. In our studies, we found that Pin1 promotes hBora degradation through the β-TrCP-mediated ubiquitin-proteasome pathway. Furthermore, Pin1 blocks CDC25 catalytic activity to attenuate G2/M transition. During G2, Aurora A phosphorylates Pin1 to block its substrate binding ability and induces translocation into cytosol.21 Taken together, Aurora A abolishes Pin1 mediated hBora degradation and CDC25 inhibition in G2 phase to allow mitotic entry.

Oh and Malter reported that Pin1 Ser16 is up-regulated under treatment of calyculin A, which is PP2A inhibitor.44 The result showed that PP2A dephosphorylated Pin1 at Ser16 and recover protein binding ability of Pin1. Besides, PP2A activation is important to G2/M checkpoint. Inactive PP2A decrease CDK activity and delay mitotic entry.45 Taken together, after mitotic entry, PP2A might dephosphorylates Pin1 at Ser16 to recover binding ability, and PLK1 phosphorylates Pin1 at Ser56 to increase stability. Taken together, after mitotic entry, PP2A might dephosphorylates Pin1 at Ser16 to recover binding ability,44 and PLK1 phosphorylates Pin1 at Ser56 to increase Pin1 stability.46

GSK3β-mediated phosphorylation of hBora at pSer274 and pSer278 creates potential Pin1 binding sites. One of our previous studies revealed that Ser274 and Ser278 double phosphorylated hBora was recognized by Pin1, and Pin1-mediated isomerization led to β-TrCP mediated proteasomal degradation. Degradation of hBora could release Aurora A and encourage the formation of an Aurora A-TPX2 complex. This complex targets Aurora A to the centrosomes and spindle poles and, thus, redirects Aurora A kinase activity toward distinct substrates to promote mitotic progression.43 In summary, we have described the role of Pin1 control of mitotic entry and exit. Aurora A-mediated Pin1-Ser16 phosphorylation disrupts the substrate-binding ability of Pin1 to prevent phospho-hBora from premature β-TrCP-mediated degradation at the G2/M transition. However, the activity of Pin1 is recovered through dephosphorylation at Ser16 by PP2A in mitosis. Moreover, PLK1 phosphorylation of Pin1 at Ser65 may enhance Pin1 stability by inhibiting its ubiquitination without altering its isomerase activity.46 During mitosis, active and stabilized Pin1 promotes degradation of hBora and triggers mitotic exit.

Pin1 and Wee1

Wee1 phosphorylates CDK1 on Tyr15 and inhibits its kinase activity, leading to prevention of mitotic entry in eukaryotic cells. During mitotic entry and M phase, Wee1 must to be down-regulated to allow activation of CDK1 by CDC25 phosphatase. In M phase, phosphorylation of Wee1 at Ser53 and Ser124 by PLK1 and CDK1, respectively, down-regulates Wee1 by β-TrCP mediated proteasome degradation. In addition to degradation, another Pin1-dependent mechanism was reported to inactivate Wee1 in M phase. During mitotic entry, CDK1 phosphorylates Wee1 at Ser168 to form a Pin1 binding motif. Pin1 then isomerizes phosphorylated Wee1 and blocks its activity to promote cell cycle progression.47

Conclusion

Pin1 acts as an important post-translational regulator for signal transduction and provides a molecular timer to regulate the function of many phosphoproteins, by altering protein–protein interactions, substrate dephosphorylation and degradation.2,5 Over the last decade, more than 40 proteins have been identified as Pin1 targets. Most of these are involved in cell-cycle regulation, cell growth and proliferation. However, little is known about the mechanism by which Pin1 is precisely ‘turned on’ and ‘turned off’ to promote cell cycle progression. Recently, we described the biological role of Pin1 Ser16 phosphorylation to address the unsolved question of how Pin1 acts as a negative regulator at the G2/M transition.15 However, the mechanism by which Pin1 modulates G1/S progression is awaiting discovery. Cell cycle dysregulation is highly correlated with several diseases, especially cancers. While Pin1 has been reported to be a tumor suppressor,48 other data demonstrate that Pin1 is overexpressed in several cancers, suggesting that it may act as a promoter.2 Clarification of the mechanisms by which the switch between active and inactive forms of Pin1 occurs in the cell cycle may help to define the role of Pin1 in cancer.

ACKNOWLEDGEMENTS

This review was supported by The National Health Research Institutes (NHRI-EX103-10152SI) and Ministry of Science and Technology (MOST 103-2320-B-006-048-).

Author contributions

All authors participated in writing, editing, and discussion of the manuscript. CHL and HYL contributed equally to this paper.

References

  • 1.Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang DG. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 2004; 164: 1727–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yeh ES, Means AR. PIN1, the cell cycle and cancer. Nat Rev Cancer 2007; 7: 381–8. [DOI] [PubMed] [Google Scholar]
  • 3.Driver JA, Lu KP. Pin1: a new genetic link between Alzheimer's disease, cancer and aging. Curr Aging Sci 2010; 3: 158–65. [DOI] [PubMed] [Google Scholar]
  • 4.Lee TH, Pastorino L, Lu KP. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev Mol Med 2011; 13: e21. [DOI] [PubMed] [Google Scholar]
  • 5.Liou YC, Zhou XZ, Lu KP. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci 2011; 36: 501–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 2003; 63: 6244–51. [PubMed] [Google Scholar]
  • 7.Lin FC, Lee YC, Goan YG, Tsai CH, Yao YC, Cheng HC, Lai WW, Wang YC, Sheu BS, Lu PJ. Pin1 positively affects tumorigenesis of esophageal squamous cell carcinoma and correlates with poor survival of patients. J Biomed Sci 2014; 21: 75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ryo A, Liou YC, Wulf G, Nakamura M, Lee SW, Lu KP. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 2002; 22: 5281–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rustighi A, Tiberi L, Soldano A, Napoli M, Nuciforo P, Rosato A, Kaplan F, Capobianco A, Pece S, Di Fiore PP, Del Sal G. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat Cell Biol 2009; 11: 133–42. [DOI] [PubMed] [Google Scholar]
  • 10.Rustighi A, Zannini A, Tiberi L, Sommaggio R, Piazza S, Sorrentino G, Nuzzo S, Tuscano A, Eterno V, Benvenuti F, Santarpia L, Aifantis I, Rosato A, Bicciato S, Zambelli A, Del Sal G. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO Mol Med 2014; 6: 99–119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lee KH, Lin FC, Hsu TI, Lin JT, Guo JH, Tsai CH, Lee YC, Lee YC, Chen CL, Hsiao M, Lu PJ. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1. Biochim Biophys Acta 2014; 1843: 2055–66. [DOI] [PubMed] [Google Scholar]
  • 12.Luo ML, Gong C, Chen CH, Lee DY, Hu H, Huang P, Yao Y, Guo W, Reinhardt F, Wulf G, Lieberman J, Zhou XZ, Song E, Lu KP. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. Cancer Res 2014; 74: 3603–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wang HY, Fu JC, Lee YC, Lu PJ. Hyperthermia stress activates heat shock protein expression via propyl isomerase 1 regulation with heat shock factor 1. Mol Cell Biol 2013; 33: 4889–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006; 127: 635–48. [DOI] [PubMed] [Google Scholar]
  • 15.Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996; 380: 544–7. [DOI] [PubMed] [Google Scholar]
  • 16.Crenshaw DG, Yang J, Means AR, Kornbluth S. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J 1998; 17: 1315–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.You H, Zheng H, Murray SA, Yu Q, Uchida T, Fan D, Xiao ZX. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J Cell Biochem 2002; 84: 211–6. [DOI] [PubMed] [Google Scholar]
  • 18.Atchison FW, Capel B, Means AR. Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development 2003; 130: 3579–86. [DOI] [PubMed] [Google Scholar]
  • 19.Shen M, Stukenberg PT, Kirschner MW, Lu KP. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev 1998; 12: 706–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lu PJ, Zhou XZ, Liou YC, Noel JP, Lu KP. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J Biol Chem 2002; 277: 2381–4. [DOI] [PubMed] [Google Scholar]
  • 21.Lee YC, Que J, Chen YC, Lin JT, Liou YC, Liao PC, Liu YP, Lee KH, Lin LC, Hsiao M, Hung LY, Huang CY, Lu PJ. Pin1 acts as a negative regulator of the G2/M transition by interacting with the Aurora-A-Bora complex. J Cell Sci 2013; 126: 4862–72. [DOI] [PubMed] [Google Scholar]
  • 22.Liou YC, Ryo A, Huang HK, Lu PJ, Bronson R, Fujimori F, Uchida T, Hunter T, Lu KP. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci U S A 2002; 99: 1335–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G, Gu L, Tang X, Lu KP and Xiao ZX. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002; 419: 849–53. [DOI] [PubMed] [Google Scholar]
  • 24.Zhou W, Yang Q, Low CB, Karthik BC, Wang Y, Ryo A, Yao SQ, Yang D, Liou YC. Pin1 catalyzes conformational changes of Thr-187 in p27Kip1 and mediates its stability through a polyubiquitination process. J Biol Chem 2009; 284: 23980–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nature Rev Mol Cell Biol 2013; 14: 518–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 1991; 354: 494–6. [DOI] [PubMed] [Google Scholar]
  • 27.Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422–6. [DOI] [PubMed] [Google Scholar]
  • 28.Rizzolio F, Lucchetti C, Caligiuri I, Marchesi I, Caputo M, Klein-Szanto AJ, Bagella L, Castronovo M, Giordano A. Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Cell Death Differ 2012; 19: 1152–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Blaydes JP, Luciani MG, Pospisilova S, Ball HM, Vojtesek B, Hupp TR. Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription. J Biol Chem 2001; 276: 4699–708. [DOI] [PubMed] [Google Scholar]
  • 30.Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, Fornace AJ., Jr Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 1999; 18: 6845–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Buschmann T, Potapova O, Bar-Shira A, Ivanov VN, Fuchs SY, Henderson S, Fried VA, Minamoto T, Alarcon-Vargas D, Pincus MR, Gaarde WA, Holbrook NJ, Shiloh Y, Ronai Z. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol Cell Biol 2001; 21: 2743–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Milner J, Cook A, Mason J. p53 is associated with p34cdc2 in transformed cells. EMBO J 1990; 9: 2885–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volinia S, Ronai Z, Blandino G, Schneider C, Del Sal G. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002; 419: 853–7. [DOI] [PubMed] [Google Scholar]
  • 34.Mantovani F, Tocco F, Girardini J, Smith P, Gasco M, Lu X, Crook T, Del Sal G. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol 2007; 14: 912–20. [DOI] [PubMed] [Google Scholar]
  • 35.Grison A, Mantovani F, Comel A, Agostoni E, Gustincich S, Persichetti F, Del Sal G. Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin. Proc Natl Acad Sci U S A 2011; 108: 17979–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bitomsky N, Conrad E, Moritz C, Polonio-Vallon T, Sombroek D, Schultheiss K, Glas C, Greiner V, Herbel C, Mantovani F, del Sal G, Peri F, Hofmann TG. Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death. Proc Natl Acad Sci U S A 2013; 110: E4203–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Moller MB. P27 in cell cycle control and cancer. Leuk Lymphoma 2000; 39: 19–27. [DOI] [PubMed] [Google Scholar]
  • 38.Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, Gurien-West M, Clurman BE, Roberts JM. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell 2003; 12: 381–92. [DOI] [PubMed] [Google Scholar]
  • 39.Yeh ES, Lew BO, Means AR. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J Biol Chem 2006; 281: 241–51. [DOI] [PubMed] [Google Scholar]
  • 40.Suizu F, Ryo A, Wulf G, Lim J, Lu KP. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Mol Cell Biol 2006; 26: 1463–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Lee TH, Chen CH, Suizu F, Huang P, Schiene-Fischer C, Daum S, Zhang YJ, Goate A, Chen RH, Zhou XZ, Lu KP. Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. Mol Cell 2011; 42: 147–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lee YC, Liao PC, Liou YC, Hsiao M, Huang CY, Lu PJ. Glycogen synthase kinase 3 beta activity is required for hBora/Aurora A-mediated mitotic entry. Cell Cycle 2013; 12: 953–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chan EH, Santamaria A, Sillje HH, Nigg EA. Plk1 regulates mitotic Aurora A function through betaTrCP-dependent degradation of hBora. Chromosoma 2008; 117: 457–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Oh J, Malter JS. Pin1-FADD interactions regulate Fas-mediated apoptosis in activated eosinophils. J Immunol 2013; 190: 4937–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Jiang Y. Regulation of the cell cycle by protein phosphatase 2A in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2006; 70: 440–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Eckerdt F, Yuan J, Saxena K, Martin B, Kappel S, Lindenau C, Kramer A, Naumann S, Daum S, Fischer G, Dikic I, Kaufmann M, Strebhardt K. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J Biol Chem 2005; 280: 36575–83. [DOI] [PubMed] [Google Scholar]
  • 47.Watanabe N, Arai H, Iwasaki J, Shiina M, Ogata K, Hunter T, Osada H. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways. Proc Natl Acad Sci U S A 2005; 102: 11663–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Teng BL, Hacker KE, Chen S, Means AR, Rathmell WK. Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma. Mol Oncol 2011; 5: 465–74. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Experimental Biology and Medicine are provided here courtesy of Frontiers Media SA

RESOURCES